Belite Bio
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 66.24% +0.00pp
- Institutions
- 95 +2
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-02-28
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 10 buys · 26 sells
| Name | Role | Stake |
|---|---|---|
| Yu-Hsin Lin | Chairman of the Board of Directors & CEO | 0.64% |
| Hao-Yuan Chuang | Chief Financial Officer | 0.59% |
| Wan-Shan Chen | Director | 0.12% |
| Nathan Mata | Chief Scientific Officer | 0.04% |
| Hendrik Scholl | Chief Medical Officer | 0.04% |
| Xiao-Hui Chen | Director | 0.00% |
| Wei-Cheng Liaw | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-28 | Hao-Yuan Chuang | Chief Financial Officer | Other Acquisition | +5,000 | -- |
| 2026-10-28 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Other Acquisition | +5,000 | -- |
| 2026-09-30 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -500 | $163.63–170.02 |
| 2026-09-23 | Wan-Shan Chen | Director | Derivative Exercise and Retained | +13,796 | $0.44 |
| 2026-09-07 | Hao-Yuan Chuang | Chief Financial Officer | Automatic Disposition | -67,395 | $180.16–198.05 |
| 2026-09-07 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Automatic Disposition | -100,435 | $180.29–198.09 |
| 2026-08-11 | Hao-Yuan Chuang | Chief Financial Officer | Automatic Disposition | -367 | $180.00–180.57 |
| 2026-08-11 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Automatic Disposition | -365 | $180.00–180.57 |
| 2026-06-17 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -10,000 | $143.90–147.11 |
| 2026-06-15 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -10,000 | $137.61–145.02 |
| 2026-05-06 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -666 | $152.45–155.25 |
| 2026-05-05 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $151.57–156.00 |
| 2026-05-04 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $153.92–158.11 |
| 2026-05-03 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $153.50–157.49 |
| 2026-04-30 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $153.89–160.00 |
| 2026-04-29 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $155.68–158.15 |
| 2026-04-28 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $154.58–158.19 |
| 2026-04-27 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $154.65–162.14 |
| 2026-04-26 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $160.83–164.07 |
| 2026-04-23 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $157.86–162.53 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Belite Bio discussion 0 comments